Goodness Growth Reports 16% YoY Revenue Growth In Q1, Progress Regarding New York Exit
Cannabis company Goodness Growth Holdings, Inc. (CSE:GDNS) (OTCQX:GDNSF) reported financial results Tuesday for its first quarter ended March 31, 2024,…
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as a Schedule III controlled substance.
Marijuana Stock Movers For May 7, 2024
GAINERS: Kaya Holdings (OTC:KAYS) shares closed up 51.29% at $0.05 Elixinol Wellness (OTC:ELLXF) shares closed up 23.60% at…
FDA Experts Weigh In On Incannex’s CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder
Incannex Healthcare Inc., a cannabinoid and psychedelic medicine biotechnology company, announced the successful completion of a pre-investigational new drug meeting with the U.S. Food and Drug Administration (FDA) regarding the development of CannQuit-O for the treatment of opioid use disorder (OUD).A number of FDA representatives shared insights on the CannQuit-O development program during the pre-IND teleconference in addition to providing recommendations on the proposed clinical development strategy.
Cannabis Enters CPG Era: Data, Brand And Market Strategies Explained By Industry Leaders At Benzinga Conference
Explore how cannabis is adopting CPG strategies to reshape the industry. Insights from Benzinga's panel on data-driven market success.
Net Income Dip: Cannabis REIT Chicago Atlantic’s Q1 2024 Financial Results Breakdown
Get exclusive insights into Chicago Atlantic's Q1 2024 financial performance. Discover key metrics, trends, and management commentary.
Cannabis Co. C21 Investments Secures Funding For $3.5M Acquisition Of Nevada’s Deep Roots Harvest
C21 Investments announced on Monday the closing of its non-brokered private placement offering of its convertible debenture units.Under the deal, the company issued a total of 4,000 convertible debenture units at CA$1,000 ($731.375) per convertible debenture unit for aggregate gross proceeds of CA$4 million.Each convertible debenture unit offered under the private placement is comprised of one convertible debenture of the company in the principal amount of CA$1,000 convertible into the company's common shares and 1,000 detachable common share purchase warrants, with each warrant exercisable into one common share at CA$0.55 per share for 30 months from the issue date of the convertible debenture units.
Las Vegas Cannabis Powerhouse Planet 13 To Close $49M Florida Expansion Deal After Achieving Another Milestone
Planet 13 closed its previously announced sale of Planet 13 Florida, Inc. on Monday, following the previously announced approval from the Florida Office of Medical Marijuana Use in April. The Las Vegas-based vertically-integrated multi-state company sold 100% of the equity interests of Planet 13 Florida, which owns a medical marijuana treatment center license issued by the Florida Department of Health to SGW FL Enterprises, LLC, in exchange for $9 million.The wrapping up of the sale is a condition to the closing of Planet 13's pending acquisition of VidaCann, LLC.
Canopy Growth Expands U.S. Reach By Acquiring These Two Key Cannabis Brands
Canopy Growth confirms acquisitions of Wana and Jetty, enhancing its U.S. cannabis market strategy and operational synergies.
Canadian Marijuana Company Cronos Expands Into UK After Setting Up In Germany’s Nascent Market
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Tuesday that it's expanding its medical brand, PEACE NATURALS, into the United Kingdom market with its first shipment of cannabis flower to GROW Pharma.The Toronto-based cannabis company has partnered with a distributor of prescribed medicinal cannabis products in the UK after years of investing in research and development, tissue culture, and its cannabis genetics breeding program.The debut in the UK follows the company's expansion in Germany and Australia last year, after successfully expanding across Canada and Israel.